<table id="table6" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6:          Mean (%CV) NGMN and EE Steady State Pharmacokinetic Parameters Following Application of ORTHO EVRA and Once-Daily Administration of an Oral Contraceptive (containing NGM 250 mcg / EE 35 mcg) in Healthy Female Volunteers</caption>
<col align="left" valign="top" width="30%"></col>
<col align="center" valign="top" width="35%"></col>
<col align="center" valign="top" width="35%"></col>
<thead>
<tr>
<th>Parameter</th>
<th>ORTHO EVRA<footnote>Cycle 2, Week 3</footnote>
</th>
<th>ORAL CONTRACEPTIVE<footnote>Cycle 2, Day 21</footnote>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Botrule">NGMN<footnote>NGM is rapidly metabolized to NGMN following oral administration</footnote>
</td>
<td></td>
<td></td>
</tr>
<tr>
<td>C<sub>max</sub> (ng/mL)</td>
<td>1.12 (33.6)</td>
<td>2.16 (25.2)</td>
</tr>
<tr>
<td>AUC<sub>0–168</sub> (ng∙h/mL)</td>
<td>145 (36.8)</td>
<td>123 (30.2)<footnote id="t6f1">Average weekly exposure, calculated as AUC<sub>24</sub> × 7</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td>C<sub>ss </sub>(ng/mL)</td>
<td>0.888 (36.6)</td>
<td>0.732 (30.2)<footnote id="t6f2">C<sub>avg</sub>
</footnote>
</td>
</tr>
<tr>
<td stylecode="Botrule">EE</td>
<td></td>
<td></td>
</tr>
<tr>
<td>C<sub>max</sub> (pg/mL)</td>
<td>97.4 (31.6)</td>
<td>133 (27.7)</td>
</tr>
<tr>
<td>AUC<sub>0–168</sub> (pg∙h/mL)</td>
<td>12,971 (33.1)</td>
<td>8,281 (26.9)<footnoteref idref="t6f1"></footnoteref>
</td>
</tr>
<tr>
<td>C<sub>ss </sub>(pg/mL)</td>
<td>80.0 (33.5)</td>
<td>49.3 (26.9)<footnoteref idref="t6f2"></footnoteref>
</td>
</tr>
</tbody>
</table>